{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":905759488,"fmt":"905.76M","longFmt":"905,759,488"},"forwardPE":{},"profitMargins":{"raw":0.07333,"fmt":"7.33%"},"floatShares":{"raw":554299,"fmt":"554.3k","longFmt":"554,299"},"sharesOutstanding":{"raw":9350520,"fmt":"9.35M","longFmt":"9,350,520"},"sharesShort":{},"sharesShortPriorMonth":{},"sharesShortPreviousMonthDate":{},"dateShortInterest":{},"sharesPercentSharesOut":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":-0.401,"fmt":"-0.4"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":13.437,"fmt":"13.44"},"priceToBook":{"raw":4.4206295,"fmt":"4.42"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1341014400,"fmt":"2012-06-30"},"earningsQuarterlyGrowth":{"raw":0.821,"fmt":"82.10%"},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":25024828,"fmt":"25.02M","longFmt":"25,024,828"},"trailingEps":{"raw":2.676,"fmt":"2.68"},"forwardEps":{},"pegRatio":{},"lastSplitFactor":null,"lastSplitDate":{},"enterpriseToRevenue":{"raw":2.654,"fmt":"2.65"},"enterpriseToEbitda":{"raw":11.956,"fmt":"11.96"},"52WeekChange":{"raw":"Infinity","fmt":"âˆž%"},"SandP52WeekChange":{"raw":0.17201865,"fmt":"17.20%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"summaryProfile":{"address1":"Ilyas Mohammed Khan Estate","address2":"3rd Floor # 8-2-672/ 5 & 6, Road No.1 Banjara hills","city":"Hyderabad","zip":"500034","country":"India","phone":"91 40 6509 0006","website":"http://www.vivobio.com","industry":"Biotechnology","sector":"Healthcare","longBusinessSummary":"Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, etc. It offers biologic research services, including molecular biology services, mutation screening by growth promotion tests, process development and scale-up of recombinant proteins, protein purification and characterization, cell based assay development, stability studies, raising polyclonal antibodies and purification, and method development and validation for biologics. The company also provides in-vitro services and screening programs, such as AMES, micronucleus, chromosomal aberration, neutral red uptake, oxidative DNA damage, and SHE cell transformation assay, as well as various in-vitro ADME services to support drug development program. In addition, it offers in-vivo services comprising preclinical testing services in rodents/non-rodents, and canines for the evaluation of toxicity, pharmacological properties, and ADME and PK properties of drug candidates in early stage development process. Further, Vivo Bio Tech Limited is involved in pathogen screening of various specimens; and in-house breeding of specific pathogen free rodents. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.","fullTimeEmployees":183,"companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":59.4,"fmt":"59.40"},"targetHighPrice":{},"targetLowPrice":{},"targetMeanPrice":{},"targetMedianPrice":{},"recommendationMean":{},"recommendationKey":"none","numberOfAnalystOpinions":{},"totalCash":{"raw":28223386,"fmt":"28.22M","longFmt":"28,223,386"},"totalCashPerShare":{"raw":3.018,"fmt":"3.02"},"ebitda":{"raw":75758056,"fmt":"75.76M","longFmt":"75,758,056"},"totalDebt":{"raw":395860448,"fmt":"395.86M","longFmt":"395,860,448"},"quickRatio":{"raw":0.534,"fmt":"0.53"},"currentRatio":{"raw":1.18,"fmt":"1.18"},"totalRevenue":{"raw":341279520,"fmt":"341.28M","longFmt":"341,279,520"},"debtToEquity":{"raw":358.747,"fmt":"358.75"},"revenuePerShare":{"raw":36.498,"fmt":"36.50"},"returnOnAssets":{"raw":0.04818,"fmt":"4.82%"},"returnOnEquity":{"raw":0.22121,"fmt":"22.12%"},"grossProfits":{"raw":257704747,"fmt":"257.7M","longFmt":"257,704,747"},"freeCashflow":{"raw":-218037168,"fmt":"-218.04M","longFmt":"-218,037,168"},"operatingCashflow":{"raw":-56563832,"fmt":"-56.56M","longFmt":"-56,563,832"},"earningsGrowth":{"raw":0.854,"fmt":"85.40%"},"revenueGrowth":{"raw":0.18,"fmt":"18.00%"},"grossMargins":{"raw":0.75511,"fmt":"75.51%"},"ebitdaMargins":{"raw":0.22198,"fmt":"22.20%"},"operatingMargins":{"raw":0.1093,"fmt":"10.93%"},"profitMargins":{"raw":0.07333,"fmt":"7.33%"},"financialCurrency":"INR"}}],"error":null}}